Veeva vs Salesforce Life Sciences Cloud: a senior decision guide
The Veeva versus Salesforce decision should be made against operating model, validation burden, data strategy, AI roadmap, commercial-medical workflows, migration risk, and long-term platform ownership rather than licensing comparisons alone.
- Capability fit across commercial, medical, service, and data workflows
- Validation effort, compliance operating model, and audit evidence
- Migration complexity, reconciliation obligations, and cutover planning
- Agentforce, Data Cloud, and long-term AI-enabled operating roadmap
Frequently asked questions
- Should life sciences organisations replace Veeva with Salesforce Life Sciences Cloud?
- Not automatically. The right decision depends on operating model, data strategy, validation effort, commercial and medical workflow needs, integration estate, and the organisation's appetite for migration risk.